Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
American Heart Association
With
Eli Lilly and Company
150 diabetic patients will be randomized to achieve aggressive glycemic control (80-120mg/dl) vs moderate control (120-180mg/dl) using intravenous insulin infusions beginning at anesthetic induction and continuing for 18 hours following surgery.
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All diabetic patients undergoing Coronary Bypass Surgery
You may not be if
Patients with hepatic and renal failure
Clareo Health | Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
